Home › Companies › STRUCTURE THERAPEUTICS INC. › 2024-2025

STRUCTURE THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and STRUCTURE THERAPEUTICS INC.’s Form 8-K, filed 2025-06-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
162Asset managers
846Fund votes
2025-06-23Meeting date

Proxy season: 2024-2025 2025-2026

Explore STRUCTURE THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by STRUCTURE THERAPEUTICS INC.

These tallies are STRUCTURE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

STRUCTURE THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-23
Ballot item	For	Against	Abstain	Withheld	Outcome
Elect Director: Eric Dobmeier	133,703,367	596,667	58,398	--	Majority: yes
Elect Director: Joanne Waldstreicher, M.D.	131,397,750	2,896,656	64,026	--	Majority: yes
Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's shareholders ratified the appointment by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered	134,291,886	27,066	39,480	--	Majority: yes
Proposal 3: Advisory vote on the compensation of the Company's named executive officers On an advisory basis, the shareholders approved the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Gen	115,026,066	19,231,338	101,028	--	Majority: yes

Source: STRUCTURE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-25 — read the filing on EDGAR.

How asset managers voted at the STRUCTURE THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 162 asset managers that disclosed a STRUCTURE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of STRUCTURE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%AGAINST 14%

FOR: 115,026,066AGAINST: 19,231,338

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Advisory vote on the compensation of the Company's named executive officers On an advisory basis, the shareholders approved the compensation of the Company's named executive officers, as disclosed in the Comp”): 115,026,066 for, 19,231,338 against, per its Form 8-K filed 2025-06-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 172,610,000 outstanding shares: 67% for, 11% against (78% of the company cast a for/against vote).

The 159 asset managers below cast 84% of the shares they voted on this item FOR (45,823,122 for, 9,036,458 against).

FOR 84%AGAINST 16%

FOR: 45,823,122 (83.5%)AGAINST: 9,036,458 (16.5%)NOT VOTED: 34 (0.0%)

Largest asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN ” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	8,983,473	947,349	For
Wellington	5,912,513	0	For
Deep Track Capital, LP	4,500,000	0	For
Capital Group	0	4,488,854	Against
Vanguard	4,044,286	0	For
Janus Henderson	3,775,006	2,243	For
BVF INC/IL	1,699,655	0	For
Capital Research Global Investors	0	1,687,272	Against
RA CAPITAL MANAGEMENT, L.P.	1,339,491	0	For
Rock Springs Capital Management LP	1,135,879	0	For
AMERIPRISE FINANCIAL INC	4,756	1,117,656	Against
TCG Crossover Management, LLC	1,063,000	0	For
Federated Hermes	925,600	0	For
Vestal Point Capital, LP	881,502	0	For
FRANKLIN ADVISERS INC	728,515	0	For
JANUS INVESTMENT FUND	672,096	0	For
T. Rowe Price	631,506	0	For
ORBIMED ADVISORS LLC	563,994	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	537,495	0	For
Invesco	523,585	0	For
READYSTATE ASSET MANAGEMENT LP	510,069	0	For
Aberdeen	497,798	0	For
PRINCIPAL GLOBAL INVESTORS	491,906	0	For
Citadel	463,654	0	For
Foresite Capital Management VI LLC	420,000	0	For

Showing the 25 largest of 159 asset managers. See all 159 in the interactive database.

2. TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 62%1 YEAR 27%

The 148 asset managers below cast 100% of the shares they voted on this item FOR (1,182,051 for, 0 against).

FOR: 1,182,051 (2.2%)ONE YEAR: 33,698,260 (61.7%)1 YEAR: 14,841,545 (27.2%)1YR: 3,097,746 (5.7%)1-YR: 1,771,417 (3.2%)1-YEAR: 117 (0.0%)NOT VOTED: 34 (0.0%)

Largest asset managers voting on “TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION O” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Fidelity	0	One Year
Wellington	0	1 Year
Deep Track Capital, LP	0	1 Year
Capital Group	0	One Year
Vanguard	0	One Year
Janus Henderson	0	One Year
BVF INC/IL	0	1-Yr
Capital Research Global Investors	0	1Yr
RA CAPITAL MANAGEMENT, L.P.	0	One Year
Rock Springs Capital Management LP	0	One Year
AMERIPRISE FINANCIAL INC	0	One Year
TCG Crossover Management, LLC	1,063,000	For
Federated Hermes	0	1 Year
Vestal Point Capital, LP	0	One Year
FRANKLIN ADVISERS INC	0	One Year
JANUS INVESTMENT FUND	0	One Year
T. Rowe Price	0	One Year
ORBIMED ADVISORS LLC	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	One Year
Invesco	0	One Year
READYSTATE ASSET MANAGEMENT LP	0	1 Year
Aberdeen	0	One Year
PRINCIPAL GLOBAL INVESTORS	0	One Year
Citadel	0	One Year
Foresite Capital Management VI LLC	0	1 Year

Showing the 25 largest of 148 asset managers. See all 148 in the interactive database.

3. Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric Dobmeier

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 133,703,367AGAINST: 596,667

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Eric Dobmeier”): 133,703,367 for, 596,667 against, per its Form 8-K filed 2025-06-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 172,610,000 outstanding shares: 77% for, 0.4% against (78% of the company cast a for/against vote).

The 45 asset managers below cast 99.9% of the shares they voted on this item FOR (15,241,178 for, 86 against).

FOR 99.9%

FOR: 15,241,178 (100.0%)AGAINST: 86 (0.0%)

Largest asset managers voting on “Election of the nominees for Class II director named below to hold office until the 2028 annual general meetin” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	4,044,166	For
Fidelity	3,943,313	For
Capital Group	3,078,380	For
JANUS INVESTMENT FUND	672,096	For
Federated Hermes	462,800	For
FRANKLIN STRATEGIC SERIES	385,871	For
Columbia Threadneedle	367,503	For
Principal	350,250	For
BlackRock	329,325	For
Hartford	278,554	For
T. Rowe Price	275,405	For
Invesco	257,175	For
Aberdeen	248,899	For
Roundhill ETF Trust	79,926	For
DRIEHAUS MUTUAL FUNDS	62,127	For
Delaware/Macquarie	58,000	For
RBB FUND, INC.	55,813	For
Northwestern Mutual	50,227	For
Elevation Series Trust	38,249	For
Morgan Stanley	32,017	For
John Hancock	30,223	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	26,700	For
Tema ETF Trust	21,380	For
Brighthouse	16,581	For
Brinker Capital Destinations Trust	13,815	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

4. Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Joanne Waldstreicher, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 131,397,750AGAINST: 2,896,656

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joanne Waldstreicher, M.D.”): 131,397,750 for, 2,896,656 against, per its Form 8-K filed 2025-06-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 172,610,000 outstanding shares: 76% for, 2% against (78% of the company cast a for/against vote).

The 45 asset managers below cast 98% of the shares they voted on this item FOR (14,925,599 for, 315,665 against).

FOR 98%

FOR: 14,925,599 (97.9%)AGAINST: 315,665 (2.1%)

Largest asset managers voting on “Election of the nominees for Class II director named below to hold office until the 2028 annual general meetin” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	4,044,166	0	For
Fidelity	3,943,313	0	For
Capital Group	3,078,380	0	For
JANUS INVESTMENT FUND	672,096	0	For
Federated Hermes	462,800	0	For
FRANKLIN STRATEGIC SERIES	385,871	0	For
Columbia Threadneedle	367,503	0	For
Principal	350,250	0	For
BlackRock	329,325	0	For
Hartford	278,554	0	For
T. Rowe Price	275,405	0	For
Invesco	0	257,175	Against
Aberdeen	248,899	0	For
Roundhill ETF Trust	79,926	0	For
DRIEHAUS MUTUAL FUNDS	62,127	0	For
Delaware/Macquarie	0	58,000	Against
RBB FUND, INC.	55,813	0	For
Northwestern Mutual	50,227	0	For
Elevation Series Trust	38,249	0	For
Morgan Stanley	32,017	0	For
John Hancock	30,223	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	26,700	0	For
Tema ETF Trust	21,380	0	For
Brighthouse	16,581	0	For
Brinker Capital Destinations Trust	13,815	0	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

5. To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 134,291,886AGAINST: 27,066

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's shareholders ratified the appointment by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP”): 134,291,886 for, 27,066 against, per its Form 8-K filed 2025-06-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 172,610,000 outstanding shares: 78% for, 0.1% against (78% of the company cast a for/against vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (15,241,264 for, 0 against).

FOR 100%

FOR: 15,241,264 (100.0%)

Largest asset managers voting on “To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	4,044,166	For
Fidelity	3,943,313	For
Capital Group	3,078,380	For
JANUS INVESTMENT FUND	672,096	For
Federated Hermes	462,800	For
FRANKLIN STRATEGIC SERIES	385,871	For
Columbia Threadneedle	367,503	For
Principal	350,250	For
BlackRock	329,325	For
Hartford	278,554	For
T. Rowe Price	275,405	For
Invesco	257,175	For
Aberdeen	248,899	For
Roundhill ETF Trust	79,926	For
DRIEHAUS MUTUAL FUNDS	62,127	For
Delaware/Macquarie	58,000	For
RBB FUND, INC.	55,813	For
Northwestern Mutual	50,227	For
Elevation Series Trust	38,249	For
Morgan Stanley	32,017	For
John Hancock	30,223	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	26,700	For
Tema ETF Trust	21,380	For
Brighthouse	16,581	For
Brinker Capital Destinations Trust	13,815	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

6. 14A Executive Compensation Vote Frequency TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 77%1 19%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (117,120 for, 0 against).

FOR: 117,120 (76.9%)1: 28,433 (18.7%)1 YEAR: 6,766 (4.4%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREH” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Pier Capital, LLC	115,820	For
RBB FUND, INC.	0	1
Focus Partners Wealth	0	1 Year
Dunham Funds	1,300	For
River Street Advisors LLC	0	1 Year

7. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

13%ONE YEAR 87%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (2,488 for, 0 against).

FOR: 2,488 (13.3%)ONE YEAR: 16,241 (86.7%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at STRUCTURE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Desjardins Global Asset Management Inc.	0	One Year
ANTIPODES PARTNERS Ltd	2,488	For
MILLER HOWARD INVESTMENTS INC /NY	0	One Year

Largest STRUCTURE THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of STRUCTURE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 172,610,000 shares outstanding at the time of that meeting.

Top STRUCTURE THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	5.75%
2	Wellington	3.43%
3	Deep Track Capital, LP	2.61%
4	Capital Group	2.60%
5	Vanguard	2.34%
6	Janus Henderson	2.19%
7	BVF INC/IL	0.98%
8	Capital Research Global Investors	0.98%
9	RA CAPITAL MANAGEMENT, L.P.	0.78%
10	Rock Springs Capital Management LP	0.66%

Reported STRUCTURE THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

STRUCTURE THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Entities affiliated with FMR LLC	13.66%	DEF14A
Entities affiliated with Wellington Management Group LLP	13.50%	DEF14A
Entities affiliated with Janus Henderson Group plc	7.23%	DEF14A
Deep Track Capital, LP	7.15%	13G
Entities affiliated with Capital Research Global Investors	6.14%	DEF14A
BVF PARTNERS L P/IL	6.05%	13G
Entities affiliated with Deep Track Capital, LP	5.21%	DEF14A
FMR (Fidelity)	3.41%	13F
JANUS HENDERSON GROUP PLC	2.58%	13G
Raymond Stevens, Ph.D.	2.19%	DEF14A

Percentages above are of 172,610,000 shares outstanding, as reported by STRUCTURE THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from STRUCTURE THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At STRUCTURE THERAPEUTICS INC.'s shareholder meeting held 2025-06-23, in the 2024-2025 proxy season, 162 asset managers reported how they voted in their SEC Form N-PX filings, covering 846 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — FOR was 86% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: STRUCTURE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-25.

STRUCTURE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.